Related references
Note: Only part of the references are listed.A Comparative Study of Antiviral Therapy After Resection of Hepatocellular Carcinoma in the Immune-Active Phase of Hepatitis B Virus Infection
Nan Li et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma
Teiji Kuzuya et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Candidates for therapy: HBV
G Dusheiko
JOURNAL OF HEPATOLOGY (2006)
Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma
JW Jang et al.
JOURNAL OF HEPATOLOGY (2004)
Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2003)
Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma
CA Liao et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Effects of long-term postoperative interferon-α therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma -: A randomized, controlled trial
S Kubo et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
